hearing loss
UK's NICE to Accelerate Assessment of Genedrive Test
NICE plans to assess Genedrive's MT-RNR1 test for antibiotics-induced hearing loss in infants via a new program.
The assay and point-of-care device were implemented in a trial in cooperation with clinical partners based at Manchester University NHS Foundation Trust.
Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays
Premium
The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30.
Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss
Qualifying children will have free access to Invitae's Comprehensive Deafness Panel, which assesses multiple genes linked to syndromic and non-syndromic deafness.
UK Newborn Trial to Assess PCR Test for Antibiotic-Induced Hearing Loss
The pharmacogenetic test, which runs on a platform from British company Genedrive, will be tested in two neonatal intensive care units in Manchester and Liverpool.
Aug 23, 2019
Jun 12, 2019
Apr 11, 2018